Used primarily in pharmaceutical research as a selective sigma receptor ligand, particularly targeting sigma-1 and sigma-2 receptors. These receptors are implicated in neurological and psychiatric disorders, making the compound valuable in studies related to pain modulation, neuroprotection, and potential anticancer therapies. It has also been investigated for its role in cellular signaling pathways associated with apoptosis and neurodegenerative diseases. Due to its ability to cross the blood-brain barrier, it is useful in central nervous system drug development. Commonly employed in radiolabeled form for receptor binding assays and imaging studies to map receptor distribution in tissues.